Cochrane Abstracts
Terazosin for benign prostatic hyperplasia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Terazosin for Benign Prostatic Hyperplasia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435721/all/Terazosin_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review.
Terazosin for benign prostatic hyperplasia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435721/all/Terazosin_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review. Accessed November 22, 2024.
Terazosin for benign prostatic hyperplasia: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435721/all/Terazosin_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review
Terazosin for Benign Prostatic Hyperplasia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435721/all/Terazosin_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Terazosin for benign prostatic hyperplasia: Cochrane systematic review
ID - 435721
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435721/all/Terazosin_for_benign_prostatic_hyperplasia:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
